Library design
We customizing libraries by starting from commercially available 'drug-like' compounds - thus ensuring maximal diversity for a user-defined number of molecules.

Lead optimization
Focussed screening of small-sized libraries (< 500 compounds) against a macromolecular target for which hits/leads have already been identified.

Virtual screening
From among 5 million commercially available compounds, we pick the most likely hits for your target on the basis of either a known pharmacophore or the 3-D structure of an active site.

Ligand profiling
Selectivity profiling: we identify secondary targets for a known hit/lead via in silico proprietary strategies.

For each project, required resources are measured in terms of FTEs.